BIOA vs ESS · rev $9.0M vs P/E 31, rev $1.89B
BioAge Labs, Inc (BIOA) versus Essex Property Trust Inc (ESS) — a side-by-side from cached financials, not a winner call.
BioAge Labs, Inc (BIOA) is a drug manufacturers - specialty & generic company listed on US.
Essex Property Trust Inc (ESS) is a reit - residential company listed on NYSE.
Latest reported BIOA revenue for 2025-12-31 was $9.0M. Net income was -$80.6M. BIOA currently screens at market cap $697.9M.
Latest reported ESS revenue for 2025-12-31 was $1.89B. Net income was $702.8M. Revenue was up 6.4% from 2024-12-31 to 2025-12-31. ESS currently screens at market cap $18.91B and trailing P/E 30.9.
BIOA currently screens at market cap $697.9M. ESS currently screens at market cap $18.91B and trailing P/E 30.9.
Not investment advice. Open the BIOA and ESS stock pages for the full models.
Not investment advice.